Evaluating the Role of Autologous Mesenchymal Stem Cell Seeded on Decellularized Pericardium in the Treatment of Myocardial Infarction: An Animal Study Publisher Pubmed



Kajbafzadeh AM¹ ; Tafti SHA² ; Khorramirouz R¹ ; Sabetkish S¹ ; Kameli SM¹ ; Orangian S¹ ; Rabbani S² ; Oveisi N¹ ; Golmohammadi M¹ ; Kashani Z¹ Show Affiliations
Source: Cell and Tissue Banking Published:2017

Abstract

Inappropriate left ventricular remodeling following myocardial infarction (MI) can result in subsequent severe dysfunction. In this study, we tested the hypothesis that decellularized pericardium (DP) or seeded pericardial patch with autologous adipose-derived mesenchymal stem cells (ADMSCs) could be safely used in a MI scar and could improve heart function. Twelve rabbits were randomly divided into three equal groups. Four weeks after MI induction by ligation of the left anterior descending artery in 12 rabbits, animals of G1 (n = 4) received DP patch with labeled ADMSCs. DP patch was implanted in animals of G2 (n = 4). Rabbits of G3 (n = 4) remained without any intervention after MI induction (control group). Serial examinations including echocardiography, electrocardiography (ECG), scanning electron microscopy, histology and immunohistochemistry (IHC) were performed to evaluate the efficacy of the implanted scaffolds on recovery of the infracted myocardium. The results demonstrated that left ventricular contractile function and myocardial pathological changes were significantly improved in rabbits implanted with either DP or ADMSC-seeded pericardium. However, the seeded pericardium was more effective in scar repairing 2 months after the operation, IHC staining with Desmin and CD34 and positive immunofluorescence staining verified the differentiation of ADMSCs to functional cardiomyocytes. This approach may involve the application of autologous ADMSCs seeded on pericardial patch in an attempt to regenerate a contractible myocardium in an animal model of MI. © 2017, Springer Science+Business Media Dordrecht.